Laboratory tests of iron status: correlation or common sense?

• Published in: Clinical chemistry (Baltimore, Md.) Vol. 42; no. 5; pp. 718 - 724
• Main Authors: Hastka, J, Lasserre, JJ, Schwarzbeck, A, Reiter, A, Hehlmann, R
• Format: Journal Article Conference Proceeding
• Language: English
• Published: Washington, DC Am Assoc Clin Chem 01.05.1996; American Association for Clinical Chemistry
• Subjects: Anemia, Iron-Deficiency - blood; Anemia, Iron-Deficiency - diagnosis; Anemias. Hemoglobinopathies; Biological and medical sciences; Diseases of red blood cells; Erythrocyte Indices; Erythropoiesis; Female; Ferritins - analysis; Hematologic and hematopoietic diseases; Humans; Iron - analysis; Iron - deficiency; Male; Medical sciences; Nutritional Status; Protoporphyrins - blood; Reference Values; Transferrin - analysis; Transferrin - metabolism; Human; Ferroprotein; Biological fluid; Hemoprotein; Anemia; Deficiency; Ferritin; Biological marker; Exploration; Hemopathy; Iron; Blood; Erythroblast; Protoporphyrin; Clinical biology; Hemoglobin; Bone marrow; Diagnosis
• ISSN: 0009-9147; 1530-8561
• DOI: 10.1093/clinchem/42.5.718

We demonstrate that simple correlation between the various tests of iron status is not sufficient for examining their value in diagnosing iron deficiency (ID). Three degrees of ID are recognized: Iron depletion (ID grade I) is defined by decreased total body iron and normal iron support to erythropoiesis, as diagnosed by decreased storage iron, decreased ferritin, normal sideroblast count, normal zinc protoporphyrin (ZPP), and transferrin saturation >15%. When the iron supply to erythropoiesis becomes insufficient, as diagnosed by transferrin saturation < or = 15%, increased ZPP, and decreased sideroblast count, iron-deficient erythropoiesis (ID grade II) occurs. When finally hemoglobin is below its normal range, iron-deficiency anemia (ID grade III) results. The various tests for ID cannot be compared without taking into account the severity of the deficiency. Depending on the grade of ID examined, the correlation of markers seen in our patients' data varied considerably. We conclude that a "best" marker of ID does not exist. However, the different tests efficiently complement each other by detecting different stages and individually show the clinical extent of ID. Ferritin reflects the iron stores. ZPP indicates whether the ID in a given patient is clinically relevant or not. Finally, the extent of a clinically relevant ID can be assessed by the measured ZPP, hemoglobin concentration, and red cell indices.